Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways

Pulmonary arterial hypertension (PAH) is a chronic and progressive disorder characterized by vascular remodeling of the small pulmonary arteries, resulting in elevated pulmonary vascular resistance and ultimately, right ventricular failure. Expanded understanding of PAH pathophysiology as it pertain...

Descripción completa

Detalles Bibliográficos
Autores principales: Mandras, Stacy, Kovacs, Gabor, Olschewski, Horst, Broderick, Meredith, Nelsen, Andrew, Shen, Eric, Champion, Hunter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261771/
https://www.ncbi.nlm.nih.gov/pubmed/33836637
http://dx.doi.org/10.1177/10742484211006531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261771/
https://www.ncbi.nlm.nih.gov/pubmed/33836637
http://dx.doi.org/10.1177/10742484211006531

Ejemplares similares